Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Biosciences to Provide Customized Laboratory Workflow System to Windber

NEW YORK, Nov. 3 (GenomeWeb News) - Amersham Biosciences has signed agreement to design a customized version of its Scierra Solutions laboratory workflow system for the Windber Research Institute,   for  use in Windber's clinical breast cancer project, the company said today.

 

Windber, of Windber, Pa., has already been using Scierra systems for gene expression, sequencing, genotyping, and proteomics. The new system ads the capability of ing information on patient histories, patient samples, and pathology, and being integrated with the company's genomics and proteomics data, according to both parties.

 

"This first of a kind advanced workflow system links clinical data and pathology information collected on patient samples with data from our research laboratories resulting in a comprehensive data warehouse that is unrivalle in breast cancer research, Richard Somiari, Chief Operating/Scientific Officer at the Windber Research Institute, said in a statement."

 

The parties did not disclose the financial terms of the agreement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.